WELL’s clinic recruitment, absorption and acquisition program has demonstrated substantial growth and capital efficiency having added two Canadian clinics in Q4-2023 generating approximately $28 million in annualized revenues for total… Read More
VANCOUVER, BC – Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust and expansive lipid nanoparticle (LNP) patent portfolio, announced it has entered into a… Read More
The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, the Honourable Mark Holland, Minister of Health, and the Honourable Dominic LeBlanc, Minister of Public Safety, Democratic Institutions and Intergovernmental… Read More
On January 5, the U.S. Food and Drug Administration (FDA) approved the state of Florida’s plan to import select Canadian prescription drugs in bulk. Since the statement issued by Health Canada last… Read More
Advancing INM-901 as a multimodal treatment option for Alzheimer’s Disease Advancing INM-089 in the treatment of Age-related Macular Degeneration Actively seeking partnerships to advance INM-755 in Dermatology BayMedica subsidiary continues… Read More
